Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.955 EUR | +0.26% | +1.30% | +79.36% |
May. 16 | GeNeuro SA Announces Last Patient Last Visit in Its Post-Covid Trial and Confirms Top-Line Results by End of June 2024 | CI |
Mar. 20 | Geneuro SA Announces Appointments of Board of Directors | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+79.36% | 62.59M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- GNRO Stock
- News GeNeuro SA
- GeNeuro Announces Resignation of Andrew Parker as Independent Director